Erythropoietin (subcutaneous or intravenous at varying dosages) vs placebo
Adverse events and drug reactions · anemia in patients with rheumatoid arthritis
1 finding from 1 review
- Erythropoiesis‐stimulating agents for anemia in rheumatoid arthritis 2013 · Cochrane Headline outcomes onlyno estimate extracted1 study · 3 participantsVery low